Ann: PainChek partners with Eldermark to expand US market reach, page-2

Great work by the team. They are really starting on the right foot with US entry. Also must be getting some great feedback from FDA. The trial results were as expected and we know that there will be no adverse effects to patients, giddy up people.

This agreement integrates PainChek’s technology, into Eldermark’s comprehensive electronic health record (EHR) and medication administration record (EMAR) systems. The collaboration enhances care coordination by enabling seamless documentation of pain assessments, improving compliance, and streamlining workflows for senior living providers, potentially saving up to 56 hours of administrative time monthly, as seen with Eldermark’s existing platform efficiencies.

The partnership offers significant benefits for both companies and their clients. For residents, combining PainChek’s pain management tools with Eldermark’s analytics (e.g., ElderSmarts) could reduce distress by up to 40%, falls by 20%, and medication errors by 40%, enhancing quality of life. For providers, the integration supports regulatory compliance and funding claims through detailed pain analytics while potentially boosting revenue by up to $1,263 per resident monthly by attracting more residents through improved care quality. Additionally, the partnership accelerates PainChek’s expansion into the US market by leveraging Eldermark’s established client base and contact center, building on PainChek’s existing North American presence through partnerships like PointClickCare.

Bring it on! There also seems to be a lack of shares available also. well pre market anyway.